• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds

    3i Solutions Announces New Leadership Positions

    INS Nutra Opens Gummy Manufacturing Facility

    Vital Nutrients Launches First Vegan Omega Supplement with SPMs

    Earth Mama Organics Achieves 'Plastic Neutral' Certification
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds

    Vital Nutrients Launches First Vegan Omega Supplement with SPMs

    Bill Chioffi Joins Nammex as Chief Strategy and Innovation Officer

    FDA Issues ‘No Questions’ Letter for Chiber Mushroom Fiber Preservative

    VITAL Ancillary Study Finds No Link Between Vitamin D and Bone Fracture Risk
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds

    3i Solutions Announces New Leadership Positions

    INS Nutra Opens Gummy Manufacturing Facility

    Vital Nutrients Launches First Vegan Omega Supplement with SPMs

    Earth Mama Organics Achieves 'Plastic Neutral' Certification
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds

    Vital Nutrients Launches First Vegan Omega Supplement with SPMs

    VITAL Ancillary Study Finds No Link Between Vitamin D and Bone Fracture Risk

    Krill Oil Study Provides Evidence of Osteoarthritis Benefits

    Immunobiotic Heat-Killed Bacteria Linked to Skin Benefits
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    PhytoGaia Inc

    Sabinsa Corporation

    BGG World

    Aiya America, Inc. (Aiya Matcha)

    Botanic Healthcare LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    PhytoGaia Inc

    Sabinsa Corporation

    BGG World

    Aiya America, Inc. (Aiya Matcha)

    Botanic Healthcare LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    New Studies Published On Sabinsa’s Probiotic Lactospore

    Several new studies demonstrate safety, stability and efficacy.

    Related CONTENT
    • Transforming Health with Nature’s Sunshine
    • Understanding FTC Standards for Claims Substantiation
    • TREHA Trehalose Available As ‘Natural Flavor’
    • ConsumerLab.com Tests Popular Vitamin D Supplements
    • Gottlieb Confirmed to Lead FDA
    07.14.16
    Sabinsa’s shelf-stable LactoSpore probiotic has been extensively researched in the 20 years since it was introduced, and recently several new studies, including clinical studies, have been published. Areas researched include safety and tolerability, shelf life stability, genetic and phenotypic stability, and anti-diarrheal activity, all with positive and significant results.
     
    LactoSpore: Anti-diarrheal & Gastrointestinal motility study
    The effect of Bacillus coagulans MTCC 5856 (LactoSpore) on castor oil induced diarrhoea and gastrointestinal (GI) motility using well established in vivo studies found LactoSpore exerted dose dependent anti- diarrhea activity and reduced the faecal output (33%). It also inhibited the gastrointestinal motility. The results suggested that LactoSpore possess significant anti-diarrheal activity and therefore could be a potential agent in the management of diarrhea (International Journal of Pharma and Biosciences. 7 (1): 311-16. 2016).
     
    LactoSpore in treatment of diarrhea predominant IBS study
    A double-blind, placebo-controlled multi-centered trial was conducted to evaluate the safety and efficacy of LactoSpore in diarrhea predominant Irritable Bowl Syndrome (IBS) patients. Thirty-six newly diagnosed diarrhea predominant IBS patients were enrolled in three clinical centers. Along with standard care of treatment, 18 patients in group one received placebo while in group two, 18 patients received LactoSpore for 90 days. 
     
    Laboratory parameters, anthropometric and vital signs were within the normal clinical range during the 90 days of supplementation in placebo and LactoSpore groups. There was a significant decrease in the clinical symptoms like bloating, vomiting, diarrhea, abdominal pain and stool frequency in the patient group receiving LactoSpore when compared to placebo group (p < 0.01). Similarly, disease severity also decreased and the quality of life increased in the patient group compared to placebo group.
     
    The study concluded that LactoSpore along with standard care of treatment was found to be safe and effective in diarrhea predominant IBS patients for 90 days of supplementation. Hence, LactoSpore could be a potential agent in the management of diarrhea predominant IBS patients (Nutrition Journal.15:21. 2016).
     
    LactoSpore: Genetic and Phenotypic Consistency Findings
    That B. coagulans strain is stable over multiple years of commercial production was clearly demonstrated through this study designed to evaluate probiotic potential, in-vitro safety, product stability, genetic and phenotypic consistency of the probiotic strain used for production of LactoSpore. Phenotypic and genotypic studies proved that the commercial preparations of LactoSpore contained the same strain of B. coagulans MTCC 5856 over multiple years of commercial production.  B. coagulans MTCC 5856 strain showed probiotic potential and found to be non-mutagenic, non-cytotoxic, negative for enterotoxin genes and stable at ambient temperature (25 ± 2°C) for 36 months. Findings of this study provide confidence to use B. coagulans MTCC 5856 as a probiotic ingredient in various dietary and functional foods and health products (World Journal of Microbiology and Biotechnology32:60. 2016).
     
    LactoSpore Safety Study
    A double-blind, placebo-controlled, parallel clinical trial was conducted to evaluate the Safety and tolerability of B. coagulans MTCC 5856 at a dose of 2 billion spores per day in healthy adults. Safety and tolerability of B. coagulans MTCC 5856 was assessed over 30 days by safety laboratory parameters (blood hematology and clinical chemistry parameters), anthropometric measures (weight, BMI, blood pressure and heart rate), adverse events, Bristol stool score, tolerability questionnaire and bowel habit diary. 
     
    All laboratory parameters, anthropometric and vital sign measures remained within normal clinical range during the 30-day supplementation. There were no between group differences in bowel movements and the Bristol stool scores for participants in the placebo vs. B. coagulans MTCC group during the 30 days of supplementation. Participants also reported that B. coagulans MTCC 5856 tablets were tolerable and easy to swallow.  This study has verified that B. coagulans MTCC 5856 at a dose of 2 × 109 cfu (spores)/day was safe and tolerable in healthy participants when supplemented for 30 days. The study was conducted by an independent CRO on subjects from North American population and the study protocol was reviewed by NHPD, Canada (Journal of Clinical Toxicology. 6: 283. 2016).
     
    LactoSpore has recently obtained the approval as Natural Health Product (NHP) that allows formulators and marketing companies to market LactoSpore in Canada as NHP.  This approval renders Canadian market readily accessible by U.S. and Canadian marketing companies. Pre-approved NHP ingredients can reduce the review period of Product license application in Canada, where a pre-market approval system precedes actual marketing. LactoSpore’s approval in natural health products in Canada is also supported by Sabinsa’s Utah facility, a registered foreign site for manufacturing the NHP for the Canadian market.
     
    “The body of science on the safety and efficacy of LactoSpore continues to grow,” said Shaheen Majeed, Sabinsa marketing director. “With the recent ‘no questions’ letter from the U.S. FDA on LactoSpore’s GRAS status, and additional published studies, the demand for LactoSpore continues to surge ahead. The clinical benefits on Sabinsa’s LactoSpore is strain specific, and therefore one of kind to Sabinsa and to our customers.” 

    For more information: www.sabinsa.com
    Related Searches
    • fda
    • bacillus coagulans
    • sabinsa
    • Natural
    Related Knowledge Center
    • Immune Function
    • Research
    • Digestive Health
    Suggested For You
    Understanding FTC Standards for Claims Substantiation Understanding FTC Standards for Claims Substantiation
    Transforming Health with Nature’s Sunshine Transforming Health with Nature’s Sunshine
    TREHA Trehalose Available As ‘Natural Flavor’ TREHA Trehalose Available As ‘Natural Flavor’
    ConsumerLab.com Tests Popular Vitamin D Supplements ConsumerLab.com Tests Popular Vitamin D Supplements
    Gottlieb Confirmed to Lead FDA Gottlieb Confirmed to Lead FDA
    Building Foundations for Healthy Living Building Foundations for Healthy Living
    Balancing Mood & Sleep in a Turbulent World Balancing Mood & Sleep in a Turbulent World
    Building Trust & Adding Value  with Branded Ingredients Building Trust & Adding Value with Branded Ingredients
    Antioxidants Outlook:  Expanding Options for Aging Well Antioxidants Outlook: Expanding Options for Aging Well
    Enzymes: Essential to Wellness Enzymes: Essential to Wellness
    Go for the Gold Go for the Gold
    Nosco Becomes First to Install Second HP Indigo 30000 Digital Press Nosco Becomes First to Install Second HP Indigo 30000 Digital Press
    Ingredion Launches NOVATION PRIMA 340 and 350 Functional Native Starches Ingredion Launches NOVATION PRIMA 340 and 350 Functional Native Starches
    Lactospore Validated as Shelf Stable in Functional Foods Lactospore Validated as Shelf Stable in Functional Foods
    Researchers Find Link Between IBS and Lack of Vitamin D Researchers Find Link Between IBS and Lack of Vitamin D

    Related Features

    • Dietary Supplements | Digestive Health | Healthcare Trends | Herbs & Botanicals | Quality & Safety | World Markets
      Transforming Health with Nature’s Sunshine

      Transforming Health with Nature’s Sunshine

      With a long history in the supplement market, Nature’s Sunshine remains committed to quality and innovation.
      By Sean Moloughney, Editor 06.02.17

    • Dietary Supplements | Regulations | Research
      Understanding FTC Standards for Claims Substantiation

      Understanding FTC Standards for Claims Substantiation

      Randomized clinical trials aren’t the only source of competent and reliable scientific evidence.
      By Todd Harrison, Venable 06.02.17

    • Breaking News | Flavors & Colors | Supplier News

      TREHA Trehalose Available As ‘Natural Flavor’

      With improved manufacturing process, TREHA trehalose is now produced from non-GM starch using non-GM enzymes.
      05.25.17


    • Breaking News | Industry & Market News | Testing | Vitamins

      ConsumerLab.com Tests Popular Vitamin D Supplements

      Review includes test results and quality comparisons for 44 products.
      05.22.17

    • Dietary Supplements | Healthcare Trends | Regulations
      Gottlieb Confirmed to Lead FDA

      Gottlieb Confirmed to Lead FDA

      Trade associations offer support for the confirmation.
      05.12.17

    Loading, Please Wait..
    Trending
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    • Study Examines Vitamin K2 Content In Cheese
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    Breaking News
    • Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds
    • 3i Solutions Announces New Leadership Positions
    • INS Nutra Opens Gummy Manufacturing Facility
    • Vital Nutrients Launches First Vegan Omega Supplement with SPMs
    • Earth Mama Organics Achieves 'Plastic Neutral' Certification
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds
    3i Solutions Announces New Leadership Positions
    INS Nutra Opens Gummy Manufacturing Facility
    Coatings World

    Latest Breaking News From Coatings World

    Lanxess' Entire Value Chain to Become Climate-Neutral
    Custom Cars Featuring PPG DELTRON Refinish System Take Awards at Goodguys 24th Summit
    HGTV Home by Sherwin-Williams Announces 2023 Color Collection of the Year
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Endologix's AFX2 Endovascular AAA System Earns EU Nod
    Elizabeth Coleon Joins Withings as Chief Marketing Officer
    U.K. Strengthens Medical Device Regulations
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioIVT Acquires Scottish Drug-metabolizing Enzyme Manufacturer Cypex
    Schott Creates Stand-Alone Company for its Pharma Business
    Marken to Acquire Medical Courier Business of Cedra Express
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Body Shop Expands Partnership with Uber
    COSRX Launches Vitamin E Vitalizing Sunscreen
    Weekly Recap: Kylie Makeup Lab Controversy, Glossier Pivots to Retail and Wholesale & More
    Happi

    Latest Breaking News From Happi

    Hallstar To Purchase Lanxess’ Polymer Additives Production Site in Greensboro, NC
    Uber and The Body Shop Expand On-Demand Delivery Partnership Nationwide
    Australia-Based Teeth Whitening Technology Leader White Glo Enters US Market
    Ink World

    Latest Breaking News From Ink World

    Xerox Board of Directors Names Steven Bandrowczak as CEO
    ALTANA AG to Sell Its Stake in dp polar to 3D Systems
    Weekly Recap: Zeller+Gmelin, Epple Druckfarben Lead This Week’s News Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eukalin acquires Adhesives Specialists
    EyeC unveils new inspection products
    Errol Moebius named VP of IST America
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: A New Day for Hygiene, Glatfelter Reports Q2 Results & More
    Dyper Achieves B Corp Certification
    Edgewell’s Sales Grow
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OSSIO Rolls Out OSSIOfiber Suture Anchors in U.S.
    MicroPort Navibot’s SkyWalker System Cleared by FDA
    NuVasive Inc. Reports Q2 2022 Financial Results
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Infineon Technologies AG Offers Secured NFC Tags
    Universal Display Announces 2Q 2022 Financial Results
    Xerox Board of Directors Appoints Steven Bandrowczak as CEO

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login